While featuring all sides of an issue is a hallmark of good journalism, many in the scientific community feel that the media should do a better job of separating facts from opinions.

The Philippines is promising better pay for its nurses to lure them to the front lines against COVID-19, but a legacy of exploitation and poor working conditions in the nation's hospitals has dampened the enthusiasm to answer the call.

Justice Ruth Bader Ginsburg was hospitalized Tuesday with an infection caused by a gallstone, the Supreme Court said.

As many as 20% to 25% of healthcare workers in hard-hit areas, experts say, are likely to develop disorders such as anxiety, depression or post-traumatic stress.

Shops and restaurants are selling less, but goods are still arriving at warehouses around the UK.

The Monty Python shares his lighter moments in hospital, and how humour helps us all.

The Api.ai platform lets developers seemlessly integrate intelligent voice command systems into their products to create consumer-friendly voice-enabled user interfaces. Api.ai is also the company behind Assistant, a first of its kind conversational assistant app created in 2010 that now has more than 20 million users and is the highest rated assistant app available.

AppLovin turns mobile into the medium of choice for brands by using data gathered across screens to deliver dynamic mobile ads for consumers.

Tute Genomics is opening a new door for precision medicine by enabling researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment.

We help our clients build the great companies of tomorrow by providing them with the world's meaningful business information and resources to understand it.

A global services provider, helping companies power their business with mobile, social and cloud technology from salesforce.com, Google, Workday and CSOD

Tekashi just streamed from in-home incarceration, setting an Instagram Live record with 2 million people tuning in. 6ix9ine trolled off the bat, bumping "Bad Boys" while toying with a pair of handcuffs. Tekashi got a lot off his plate ... admitting…

This is kinda shocking, but Carnival Cruise enthusiasts aren't letting the pandemic scare 'em away from boarding ships with hundreds of passengers. A rep with Cruise Planners, an American Express travel franchise, tells TMZ ... after Carnival…

Rs.4,610 - Bengaluru to Kolkata 14 Nov on SpiceJet found 0 days ago

Rs.3,500 - New Delhi to Bengaluru 1 Jun on SpiceJet found 0 days ago

The ITV host told his Twitter followers on Sunday night that he had been feeling unwell over the weekend

Rebecca is staying at home during the coronavirus pandemic with her ex Harry Needs and her partner Andrew Parsons

The music legend was credited with changing the face of music

#TTB just made changes to modernize the way that #wine, #distilledspirits, and #maltbeverages are labeled and advertised. KKB associate Dan Logan and partner Dan Dwyer highlight some of the key changes (and proposals that were rejected).

The post TTB Finalizes Portions of Modernization of Advertising and Labeling Regulations for Wine, Distilled Spirits, and Malt Beverages Rule appeared first on Kleinfeld Kaplan & Becker LLP.

Our editor Laura Hughes highlights her five must-read articles for this week.

MPN editor Laura Hughes reached out to Blake Teipel (BT), CEO and co-founder of Essentium, and Gurvinder Singh (GS), global product director, injection moulding at Protolabs, to find out how the companies were helping with the pandemic.

Diversified Plastics (DPI), a custom plastic injection moulder and additive manufacturer of high-precision components, has increased the capacity of its Acceleration Station to meet the rise in demand associated with the Covid-19 pandemic.

Our editor Laura Hughes highlights her five must-read articles for this week.

Chemicals company Lubrizol is helping with the pandemic by making materials used in Personal Protection Equipment (PPE) as well as hand sanitiser and products to help treat patients who are fighting the virus.

The research by Ben-Gurion University (BGU) and the National Institute of Biotechnology in the Negev (NIBN), has received financial support from the Israel Innovation Authority as part of a call for proposals for coping with the coronavirus.

Our editor Laura Hughes highlights her five must-read articles for this week.

Experts discuss recent cancellation of first-in-class drug

Also, CMS chief vows to lessen docs' record-keeping burden

Braeburn Pharmaceuticals' CAM2038 gets positive FDA review

Health news and commentary from around the Web gathered by the ALLMedPage Today staff

The guideline is designed to help healthcare professionals who are not kidney specialists to prevent, detect and manage AKI in hospitalised patients with suspected or confirmed COVID-19

The genetic mutations that cause epilepsy don’t stop there. Praxis Precision Medicines CEO Marcio Souza says research also links these genes to other neurological conditions. The biotech startup is turning that research into new neuro drugs and it’s coming out of stealth to share details about its science and its pipeline, which already has two […]

Kura Oncology is discontinuing development of one of its three clinical-stage cancer drug candidates amid pandemic-related impacts to its clinical trial plans. The decision to end work on the drug, KO-947, comes after San Diego-based Kura (NASDAQ: KURA) was successful in lifting a partial clinical hold placed on a Phase 1 trial of the drug […]

Chief Executive Mike Thompson is to retire from his role at the Association of the British Pharmaceutical Industry (ABPI) by the end of this year.

His decision to leave the association marks the end of a three-year run beginning in March 2016, when stepped in to take up the mantle from Alison Clough, who had served as the acting Chief Executive for much of 2015.

read more

Cerevel Therapeutics, a pharmaceutical company dedicated to treating neurological diseases, has appointed renowned biotechnology leader Tony Coles as Chief Executive Officer (CEO).

read more

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its new Chief Executive. He will assume the position on 1 January 2020.

The appointment comes after his predecessor, Mike Thompson, stepped down in June. He had served in the role since March 2016. Torbett was unanimously selected by the ABPI board after an external recruitment process with an executive search agency.

read more

A judge ruled recently that a patient, known as MB, who had occupied an NHS bed for over a year, must vacate it and instead receive care in the community.

The post Obtaining a Hospital Bed in the COVID-19 Pandemic: A Legal Perspective appeared first on Bill of Health.

A discussion of administrative decisions hospitals are making during the COVID-19 pandemic, including cutting benefits for employees and furloughing staff.

The post Hospital Administration and the COVID-19 Pandemic (Part II) appeared first on Bill of Health.

They don’t stand on one leg around just anybody but often prefer certain members of the flock.

-- Read more on ScientificAmerican.com

Big drugs companies have long favoured outsourcing clinical trials to poor countries with lax regulations to cut costs and maximise profit

• Coronavirus latest updates

• See all our coronavirus coverage

Last week, in Oxford, the first volunteers in the first European human trial were injected with a potential coronavirus vaccine. At the same time, Pakistan’s National Institute of Health received an offer from the Chinese pharmaceutical firm Sinopharm International Corp to take part in a trial of another potential coronavirus vaccine.

Related: Africa's Covid-19 research must be tailored to its realities – by its own scientists | Monique Wasunna

In India, many poor people were recruited to HIV trials without knowing that they were taking part in experiments

Exclusive: St Vincent’s in Sydney is the only confirmed location so far, as NSW Health negotiates with US pharmaceutical giant Gilead

• Remdesivir: the antiviral drug is being touted as a possible coronavirus treatment – but will it work?
• Sign up for Guardian Australia’s daily coronavirus email
• Download the free Guardian app to get the most important news notifications

The US pharmaceutical company Gilead is finalising the location of five hospitals in Australia to receive the highly sought-after experimental coronavirus drug remdesivir.

The only confirmed location is St Vincent’s hospital in Sydney, a major tertiary hospital and the centre of many of the New South Wales outbreak areas. A NSW Health spokeswoman confirmed the health department “has been engaging with Gilead on gaining access to the drug for Covid-19 patients”.

Related: Remdesivir: the antiviral drug is being touted as a possible coronavirus treatment – but will it work?

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high to end its suspension.

12 children have fallen ill across the UK with a new and potentially fatal combination of symptoms linked to COVID-19.

The Association of American Physicians and Surgeons (AAPS) wrote a letter to Republican Arizona Governor Doug Ducey urging the wider use of hydroxychloroquine, based on data they have collected.

The first findings of two new studies have been revealed detailing the efficacy of Gilead’s antiviral therapy remdesivir in the treatment of patients hospitalised with COVID-19.

Bristol Myers Squibb and Acceleron Pharma’s Reblozyl (luspatercept) has secured a positivr opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for use in the treatment of transfusion-dependent anaemia in two adult patient populations.